Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
To any MDs on our board who treats type 2 dm
I have a question for you. Please respond
And I will carefully frame the question.
Thanking you in advance .
Compare with Jaguar I pace.
Please share your thoughts
after you review all of Dr Jason Fung’s
Video on YouTube.
I enjoy your thoroughness.
Thanking you in advance.
... with 4 pills. Hope you are right
As I am on your side.
Do you think they reasonably
Know the compliance or adherence
8175 enrollees in a six years and
7 months long study?
After the topline results are out I will expand
on this. You need to see all YouTube
Videos of Dr Fung to really understand this
assuming this is of interest to you...
Dear Chas:
I have been convinced by Jason Fung, a nephrologist
that current treatment of type 2 dm is not always right.
This is where my fear lies that rrr will not be overwhelming.
By Tuesday morning we may all know the topline results...
As always all the best
To Chas, never mind as I found a reasonable answer
to
My question to you. Thanks for your contributions
to this board.
Chas:
With all due respect How did you incorporate
The type2 DM in your model? Curiosity question!!
Thanks in advance.
CONCUR.
please please try it for say 6 weeks. Then get a blood test. Your personal physician would seek your advice how you did it....
Also there is no need to resort to ignore function. So long as they provoke
you to think or provoke they are worthwhile. Else you become a dictator which is completely worthless..
No, I am not interested to change his mind, only to point out when he systematically misleads if that is necessary for the argument at hand...
Cantos study. You loser...
Pure speculation unless evaluated by potental acquirers..
Did you integrate that Apo-C3 information by your famous DR Sith… published in the New England journal of medicine?
No, because you are only inclined to support your biased thesis...
You are a sad story misleading yourself over and over for a few misplaced pennies...
That part of JL's thesis is acceptable...
Thanks for your effort in seeking the truth..
No one is ignoring him. But he is biased as all of us are....
If he was the executive PR of Reduce-IT he will speak differently....
Bottom line is you need to seek the truth and integrate
all the latest information available.
How many would dare try this? Very few...
I reiterate we will succeed in PE exceeding 15%
But impossible to exceed 30%...
Lots of type 2 dm. It is not a control... also alcohol
consumption is not a control..
Mid September earliest. While they only need to report
Topline data, they will shoot for a complete analysis including
secondary and tertiary data points.
I concur with you but I am intrigued how
RRR can be above 30 percent based on Chas1232123’s
analysis.
I am sure rrr will be above 15% for PE but
Way below 30%. That is why I am curious about his rationale.
I cut down on carbohydrate and my lipid numbers
Became stellar within just two months.
My concern is that those enrollees even with 4 grams
Of Vascepa will not be able cut down the risk dramatically
Given that they consume refined carbohydrate with little fiber freely. I strongly believe
Insulin resistance is at play here. That is why rrr in PE will not exceed
30 percent even with such high cardiovascular risk enrollees.
I understand Amarin’s thesis of choosing the right patients, right dose, and the right drug. But that
may not be enough to pull rrr over 30 percent in PE. This is just my opinion, not a fact at this point.
Thanks for responding. We will all know shortly...
All the best
To Chas1232123:
If we did not meet overwhelming efficacy at 2nd
Interim analysis why are you so confident of rrr above 30
Percent for PE at final analysis?
Just curious about your rationale...
Thanking you in advance for sharing your insights.
This is just humor. Fellow is no genius..
Gabor, please apologize to JL
For his genius prediction.
Marzan,
Did the separation started at year 6 rather than 5?
So his cronies can buy at low price...
Go to the rationale and design
if Reduce-IT. You will see PAD listed there.
When did he insult you other than pointing to your
Cunningness?
How much risk remain after ldl is optimized
Using statin and Zetia? 65 to 75 percent!
You should seek the absolute truth, not
merely supporting your thesis.
Insulin resistance will do you as ...
Kiwi, alias Akanz, apparently fromNew zealand,
Please answer his simple question:
Who has the lowest placebo rate Jelis study or
Reduce It study ?
Please please respond to Rafunrafun as you are
a. genius?
No one should reply to this winner until he responds
How can this settle the issue when
all the actors are paid by Amarin?
To reach greatness you need independent thinking
Nothing less...
Well he got it all wrong. Number one is what you eat. Period!!!
The cave woman thrive, not merely survive because
She eats only one meal a day every 8 to 12 hours.
Intermittent fasting is the key.All diets decrease metabolic rate except
Intermittent fasting which actually increases the metabolic rate.
You are a smart fellow and have a good background in statistics.
Please do not be fool by experts. Go for the absolute truth and explore.
Do not believe in me or JL but rather INTEGRATE knowledge from everyone.
First get some ufundamentals and then add up if it is new.
Example the essential macronutrients are fat,protein and fiber!!!
Now integrate the role they play in different societies in the world
And you have your answer why some thrive and why RRR cannot exceeds
30%
All the best
Dear Vubru,
Further, you are a honest person
and will distort statement of others
or person of authority. For example,
If Dr Budoff stated that Jelis deals with
Different population than Reduce-It and stated
That he agrees like fda that Jelis is supportive but
Not conclusive. You will not mislead by adding “ not
Convincing” in describing Dr. Budoff recent statement
With AF.
Dear Chas1232123:
Thank you so much for your candid response. I am also very long and believe
only in the science. I hope you are right about the overkill idea.
Thanks for bringing up the Cherry study and its timeline of plaque regression by EPA. If the participants were Japanese, then the questions still remain with regarding to timing of separations in populations where fish is not part of the staple diet.
Thanks for your response. But that is at
an early time. What about at six years and seven
months, can they accurately project the separation
Since rate of event rate is dramatically slowing
down assuming Vascepa is very effective in reducing MACE?
Dear Chas1232123:
Thank you for a detailed response.I apologize
For my question not being clear enough.
What I meant to ask is that at Six years and seven
Months can Amarin clearly see the placebo and Vascepa
are clearly separating on the KM curve based on their
Estimated placebo event rate and knowing the composite
Event rate?
For example for Jelis, you can clearly see the 19 percent difference
after a few years.
What if the separation on Reduce-IT would take place at say
8 years or 10 years, would their projections arrive at that approximate number of years?
Assuming that is true would they have dramatically increased the number of enrollees?
Thanks again for taking the time to respond?
All the best.